| Comparative analysis of AhR-mediated TCDD-elicited gene expression in human liver adult stem cells S Kim, E Dere, LD Burgoon, CC Chang, TR Zacharewski Toxicological Sciences 112 (1), 229-244, 2009 | 76 | 2009 |
| Genome-wide gene expression effects in B6C3F1 mouse intestinal epithelia following 7 and 90days of exposure to hexavalent chromium in drinking water AK Kopec, S Kim, AL Forgacs, TR Zacharewski, DM Proctor, MA Harris, ... Toxicology and applied pharmacology 259 (1), 13-26, 2012 | 59 | 2012 |
| Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing Sarcoma PJ Grohar, S Kim, GOR Rivera, N Sen, S Haddock, ML Harlow, ... Cell reports 14 (3), 598-610, 2016 | 46 | 2016 |
| Comparative toxicogenomic analysis of oral Cr (VI) exposure effects in rat and mouse small intestinal epithelia AK Kopec, CM Thompson, S Kim, AL Forgacs, TR Zacharewski Toxicology and applied pharmacology 262 (2), 124-138, 2012 | 35 | 2012 |
| Comparison of TCDD-elicited genome-wide hepatic gene expression in Sprague–Dawley rats and C57BL/6 mice R Nault, S Kim, TR Zacharewski Toxicology and applied pharmacology 267 (2), 184-191, 2013 | 30 | 2013 |
| Ewing sarcoma cells harboring a translocation that retains EWSR1 exon 8 require HNRNPH1 to express the in-frame oncogenic fusion transcript EWS-FLI1 S Kim, C Olivero, GOR Rivera, N Sen, S Haddock, K Huppi, LJ Helman, ... Cancer Research 76 (14 Supplement), 2008-2008, 2016 | | 2016 |
| Inhibition of the splicing of the EWS-FLI1 fusion transcript reverses EWS-FLI1 driven oncogenic expression in Ewing sarcoma PJ Grohar, S Kim, S Haddock, GR Rivera, M Harlow, NK Maloney, ... Cancer Research 75 (15 Supplement), 479-479, 2015 | | 2015 |
| Functional genomic screens identify microRNA regulators of the oncogenic fusion transcription factor EWS-FLI1 S Kim, PJ Grohar, C Klumpp, A Lal, SE Martin, LJ Helman, NJ Caplen Cancer Research 74 (19 Supplement), 520-520, 2014 | | 2014 |
| Abstract C222: The identification of kinase targets in Ewing sarcoma cell lines using RNAi and high-throughput investigational agents screens. A McCalla, P Grohar, S Martin, E Buehler, S Kim, N Caplen, J Morris, ... Molecular Cancer Therapeutics 12 (11 Supplement), C222-C222, 2013 | | 2013 |
